Non-Hodgkin lymphoma refractory/ relapsed

Clinical trials for Non-Hodgkin lymphoma refractory/ relapsed explained in plain language.

Never miss a new study

Get alerted when new Non-Hodgkin lymphoma refractory/ relapsed trials appear

Sign up with your email to follow new studies for Non-Hodgkin lymphoma refractory/ relapsed, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 1

Can a new immune cell therapy outsmart resistant blood cancers?

Cure Not yet recruiting

This Phase 2 trial is testing an experimental therapy called LMY-920, which uses a patient's own immune cells (T cells) engineered to recognize and attack cancer cells through a protein called BAFF. The study aims to see if this treatment can shrink tumors or eliminate signs of c…

Matched conditions: NON-HODGKIN LYMPHOMA REFRACTORY/ RELAPSED

Phase 2 • Sponsor: Luminary Therapeutics • Aim: Cure

Last updated Aug 20, 2026 00:00 UTC

Non-Hodgkin lymphoma refractory/ relapsed

Get alerted when new Non-Hodgkin lymphoma refractory/ relapsed trials appear

Can a new immune cell therapy outsmart resistant blood cancers?